Scarica l'app Stockscreener
74.67
0.46%
0.34
Precedente Chiudi:
$74.33
Aprire:
$73.02
Volume 24 ore:
282.51K
Relative Volume:
0.29
Capitalizzazione di mercato:
$6.62B
Reddito:
$5.07M
Utile/perdita netta:
$-186.75M
Rapporto P/E:
-31.88
EPS:
-2.3424
Flusso di cassa netto:
$-160.43M
1 W Prestazione:
+0.44%
1M Prestazione:
+4.58%
6M Prestazione:
+21.28%
1 anno Prestazione:
+141.34%
Intervallo 1D:
$72.87
$74.88
Intervallo di 1 settimana:
$72.12
$79.23
Portata 52W:
$29.85
$80.97
Cg Oncology Inc Stock (CGON) Company Profile
Nome
Cg Oncology Inc
Settore
Industria
Telefono
(949) 409-3700
Indirizzo
3000 PEGASUS PARK DRIVE, DALLAS
Compare CGON vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
74.67 | 6.88B | 5.07M | -186.75M | -160.43M | -2.3424 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Iniziato | Wedbush | Outperform |
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-10-08 | Iniziato | Guggenheim | Buy |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2025-05-02 | Iniziato | JP Morgan | Overweight |
| 2025-04-16 | Iniziato | Scotiabank | Sector Perform |
| 2025-01-07 | Iniziato | TD Cowen | Buy |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-09-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-08-28 | Iniziato | ROTH MKM | Buy |
| 2024-06-28 | Iniziato | BofA Securities | Buy |
| 2024-02-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-20 | Iniziato | Goldman | Neutral |
| 2024-02-20 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-14 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Cg Oncology Inc Borsa (CGON) Ultime notizie
RTW INVESTMENTS, LP Boosts CG Oncology Inc (CGON) Stake -- Shares Look 38% Undervalued on GF Value - GuruFocus
Jefferies Group's CG Oncology Inc(CGON) Holding History - GuruFocus
Investigation launched into CG Oncology officers for possible self-dealing harming shareholders - Pluang
Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm - PR Newswire
How Investors May Respond To CG Oncology (CGON) Revenue Growth Alongside a Widening Net Loss - simplywall.st
CG Oncology (NASDAQ: CGON) insider flags $7.95M stock sale after recent disposals - Stock Titan
CG Oncology stock hits all-time high of 79.5 USD By Investing.com - Investing.com Nigeria
CG Oncology stock hits all-time high of 79.5 USD - Investing.com
CG Oncology (NASDAQ:CGON) Flaunts a Perfect Technical Breakout Setup - ChartMill
CG Oncology director sells 1,000 shares at $74.54 | CGON Insider Trading - Stock Titan
Midday Stock Roundup: Eledon Falls 3.5% - Orange County Business Journal
CG Oncology (NASDAQ: CGON) insider lines up new stock sale - Stock Titan
CGON shareholder (NASDAQ: CGON) details planned 19,364-share stock sale - Stock Titan
CG Oncology (CGON) sees Foresite Capital report 4.9% beneficial stake via funds - Stock Titan
CG Oncology (CGON): RTW Investments takes 9.7% position, holding 8.5M shares - Stock Titan
CG Oncology's bladder cancer drug shows strong results with 75% response rate and no severe side effects. - Pluang
CG Oncology: Circling Back After Huge Rally - Seeking Alpha
CGON (CGON) investor lists 25,989-share sale after series of stock disposals - Stock Titan
CG Oncology (CGON) Falls 2.96% as Shares Approach Key Support at $70.97Institutional Volume - Vinanet
CG Oncology (CGON): Wellington group discloses 5.3M-share, 6.04% ownership position - Stock Titan
Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $85 - Moomoo
CGON (NASDAQ: CGON) holder files to sell 32,137 shares after option exercise - Stock Titan
CGON (CGON) insider Ambaw Bellete plans 50,000-share stock sale - Stock Titan
CG Oncology (NASDAQ:CGON) Hits New 52-Week HighShould You Buy? - marketbeat.com
CG Oncology, Inc. (CGON) Stock Analysis: A Potential 18.96% Upside In The Biotech Sector - DirectorsTalk Interviews
CGON (CGON) insider plans 50,000-share stock sale after option exercise - Stock Titan
HC Wainwright Has Weak Estimate for CG Oncology Q3 Earnings - MarketBeat
CG Oncology Inc (CGON) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $85 to $108 - Moomoo
Enterprise value to EBITDA forward of CG Oncology, Inc. – NASDAQ:CGON - TradingView
Bank of America Securities Reaffirms Their Buy Rating on CG Oncology, Inc. (CGON) - The Globe and Mail
Bank of America Corp DE Grows Holdings in CG Oncology, Inc. $CGON - MarketBeat
Wall Street Zen Downgrades CG Oncology (NASDAQ:CGON) to Strong Sell - MarketBeat
CG Oncology (NASDAQ:CGON) Posts Earnings Results, Misses Expectations By $0.24 EPS - MarketBeat
Insider Ambaw Bellete plans CGON (CGON) stock sale after large prior trades - Stock Titan
Royal Bank Of Canada Has Lowered Expectations for CG Oncology (NASDAQ:CGON) Stock Price - MarketBeat
Piper Sandler Issues Positive Forecast for CG Oncology (NASDAQ:CGON) Stock Price - MarketBeat
Truist Financial Issues Positive Forecast for CG Oncology (NASDAQ:CGON) Stock Price - marketbeat.com
A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $79 to $100 - moomoo.com
BofA Adjusts Price Target on CG Oncology to $88 From $87 - Moomoo
RBC Adjusts PT on CG Oncology to $79 From $81, Maintains Outperform Speculative Risk Rating - marketscreener.com
FY2029 EPS Estimates for CG Oncology Cut by HC Wainwright - MarketBeat
How Investors Are Reacting To CG Oncology (CGON) Wider Quarterly Loss Amid Promising Phase 3 Bladder Cancer Data - simplywall.st
CG ONCOLOGY Q2 NET INCOME USD -79.1 MILLION - Moomoo
CG Oncology, Inc. Stock 12‑Month Price Target Raised to $91.15, Implies 26% Upside - TradingView
Insider (NASDAQ: CGON) files to sell 75,000 shares after recent stock sales - Stock Titan
CG Oncology earnings up next amid bladder cancer therapy push By Investing.com - Investing.com Nigeria
CG Oncology earnings up next amid bladder cancer therapy push - Investing.com
CG Oncology Announces Q2 2026 Financial Results with Increased Revenues and Expanded Marketable Securities - Kalkine Media
CG Oncology Announces Q2 2026 Earnings and Boosts ATM Equity Offering by $500 Million - Kalkine Media
CG Oncology, Inc. reports results for the quarter ended June 30Earnings Summary - tradingview.com
Cg Oncology Inc Azioni (CGON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):